CY1119067T1 - Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο - Google Patents

Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο

Info

Publication number
CY1119067T1
CY1119067T1 CY20171100725T CY171100725T CY1119067T1 CY 1119067 T1 CY1119067 T1 CY 1119067T1 CY 20171100725 T CY20171100725 T CY 20171100725T CY 171100725 T CY171100725 T CY 171100725T CY 1119067 T1 CY1119067 T1 CY 1119067T1
Authority
CY
Cyprus
Prior art keywords
crossed
procedure
haluronic acid
aesthetic field
aesthetic
Prior art date
Application number
CY20171100725T
Other languages
English (en)
Inventor
Ugo Raffaello Citernesi
Lorenzo Beretta
Lorenzo Citernesi
Original Assignee
I.R.A. Istituto Ricerche Applicate S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I.R.A. Istituto Ricerche Applicate S.R.L. filed Critical I.R.A. Istituto Ricerche Applicate S.R.L.
Publication of CY1119067T1 publication Critical patent/CY1119067T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/95—Involves in-situ formation or cross-linking of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Abstract

Η παρούσα εφεύρεση αφορά, από μια άποψη, τη χρήση ως δερματικού πληρωτικού μέσου ενός διασταυρούμενου βιοπολυμερούς που είναι συμβατό με τους ιστούς του ανθρώπινου οργανισμού και έχει τη βάση του στο υαλουρονικό οξύ που βρίσκεται σε διασταυρούμενη σύνδεση με ουρία. Το βιοπολυμερές του υαλουρονικού οξέος και της ουρίας μπορεί να εφαρμοστεί ή να εγχυθεί σε έναν μαλακό ιστό του ανθρώπινου σώματος για την αύξηση του ιστού.
CY20171100725T 2013-07-16 2017-07-10 Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο CY1119067T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001193A ITMI20131193A1 (it) 2013-07-16 2013-07-16 Acido ialuronico reticolato, processo per la sua preparazione ed applicazioni in ambito estetico
PCT/EP2014/065237 WO2015007773A1 (en) 2013-07-16 2014-07-16 Cross-linked hyaluronic acid, process for the preparation thereof and use thereof in the aesthetic field

Publications (1)

Publication Number Publication Date
CY1119067T1 true CY1119067T1 (el) 2018-01-10

Family

ID=49182370

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100725T CY1119067T1 (el) 2013-07-16 2017-07-10 Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο

Country Status (10)

Country Link
US (1) US10117822B2 (el)
EP (1) EP3021881B1 (el)
CN (1) CN105451786B (el)
CA (1) CA2918003C (el)
CY (1) CY1119067T1 (el)
ES (1) ES2632456T3 (el)
IT (1) ITMI20131193A1 (el)
PT (1) PT3021881T (el)
RU (1) RU2686738C2 (el)
WO (1) WO2015007773A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190175784A1 (en) * 2016-08-18 2019-06-13 Prollenium Medical Technologies, Inc. Hyaluronic acid gel with high average diameter particle size, a consumer package containing the gel and a use thereof
IT201600096125A1 (it) * 2016-09-26 2018-03-26 Ntc Srl Complesso e composizioni per il trattamento di affezioni oculari e cutanee
CA3101410A1 (en) * 2018-06-15 2019-12-19 Croma-Pharma Gmbh Stabilized hyaluronic acid
US20220087250A1 (en) 2020-09-24 2022-03-24 Everest Medical Innovation GmbH Cryoprotective Compositions and Methods for Protection of a Surgical Site During Cryosurgery
CN113150187B (zh) * 2021-05-28 2022-03-25 杨彦威 一种超低分子量质酸钙与脲的络合物及其制备方法与应用
WO2023063895A1 (en) * 2021-10-12 2023-04-20 Episome Biyoteknolojik Urunler Sanayi Ticaret Anonim Sirketi Cellulose hydrolysis apparatus for use with high solids loading
EP4248946A1 (en) 2022-03-22 2023-09-27 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1238043A (en) * 1983-12-15 1988-06-14 Endre A. Balazs Water insoluble preparations of hyaluronic acid and processes therefor
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5583119A (en) * 1993-08-04 1996-12-10 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
CN1837265A (zh) * 2006-04-25 2006-09-27 江南大学 一种透明质酸－羧甲基纤维素复合改性的方法
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
GB201014388D0 (en) 2010-08-31 2010-10-13 Fujifilm Mfg Europe Bv Biocompatible compositions for tissue augmentation

Also Published As

Publication number Publication date
EP3021881A1 (en) 2016-05-25
CA2918003A1 (en) 2015-01-22
EP3021881B1 (en) 2017-04-12
RU2016104977A3 (el) 2018-05-30
RU2016104977A (ru) 2017-08-21
CN105451786A (zh) 2016-03-30
PT3021881T (pt) 2017-07-21
CN105451786B (zh) 2020-06-05
ITMI20131193A1 (it) 2015-01-17
US10117822B2 (en) 2018-11-06
CA2918003C (en) 2021-11-30
ES2632456T3 (es) 2017-09-13
RU2686738C2 (ru) 2019-04-30
US20160158140A1 (en) 2016-06-09
WO2015007773A1 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
CY1119067T1 (el) Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο
CY1123735T1 (el) Φαρμακευτικη χρηση toy fam19a5 που εμπλεκεται στη ρυθμιση γλοιογενησης
EP3030176A4 (en) Bipolar surgical instrument with tissue stop
BR112015018008A2 (pt) extensor de tecido implantável humano.
CR20130134A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
BR112016014410A2 (pt) terapia de combinação com vacina de neoantígeno
GT201200109A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
NZ729417A (en) Compositions and methods for enhancing healing and regeneration of bone and soft tissue
SG10201806020VA (en) Electroactive bioadhesive compositions
CY1120642T1 (el) Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση
BR112015017490A2 (pt) uso de nanopartículas inorgânicas
EP2958492A4 (en) TISSUE EXPANDERS, IMPLANTS AND METHODS OF USE
DOP2016000170A (es) Compuestos derivados de hidroxiformamida y usos del mismo
GEP201706716B (en) Optimised subcutaneous therapeutic agents
BR112015022825A2 (pt) métodos de diagnóstico, seleção e tratamento de doenças e condições causadas por ou associadas a metanógenos
CY1120906T1 (el) Συνθεσεις οξπρενολολης για τη θεραπεια του καρκινου
CY1121000T1 (el) Sirna και χρηση αυτου σε μεθοδους και συνθεσεις για την θεραπεια ή/και προληψη οφθαλμικων καταστασεων
BR112016028895A2 (pt) composições biofotônicas termofixas e usos destas
BR112012029546B8 (pt) processo para geração de um patch ou curativo com pele
WO2016060918A3 (en) Formulations for histatin therapeutics
NZ729181A (en) Treatment of disease with poly-n-acetylglucosamine nanofibers
BR112018012749A2 (pt) composições para higiene pessoal
CY1123344T1 (el) Μεθοδοι αγωγης οφθαλμικων καταστασεων με ενα εμφυτευμα κατακρατημενης απελευθερωσης φαρμακων
MX2015014265A (es) Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel.
CY1118118T1 (el) Συνεργατικες θεραπειες cannabidiol μαζι με υποθερμια για νευρο-προστασια